Skip to main content
. Author manuscript; available in PMC: 2017 May 31.
Published in final edited form as: J Am Coll Surg. 2016 Feb 26;222(5):750–759.e2. doi: 10.1016/j.jamcollsurg.2016.02.012

Table 3.

Results from the Bayesian Weibull Proportional Hazard Model

Node status 5-Year overall survival, % 95% CrI Hazard ratio 95% CrI
Node status actual survival* 1.54 1.21–1.98
 N0 22.4 16.5–30.4
 N1 15.4 9.9–23.9
Node status Bayesian model with 2 TNLE 1.35 0.94–1.87
 N0 23.9 17.9–30.7
 N1 16.9 9.3–24.0
Node status Bayesian model with 4 TNLE 1.51 1.13–2.02
 N0 26.9 21.3–33.0
 N1 15.0 9.3–21.7
Node status Bayesian model with 6 TNLE 1.69 1.29–2.26
 N0 29.9 23.3–37.1
 N1 14.0 9.0–19.9
Node status Bayesian model with 8 TNLE 1.89 1.39–2.62
 N0 33.1 24.6–42.2
 N1 13.1 8.4–18.8
Node status Bayesian model with 10 TNLE 2.10 1.47–3.15
 N0 36.2 25.3–47.9
 N1 12.2 7.6–18.2
*

Three-year overall survival and 95% CI estimated with the Kaplan-Meier method, hazard ratio and 95% CI estimated with a univariate Cox model.

CrI, credible interval; TNLE, total number of lymph nodes examined.